✦ LIBER ✦

Cooperative group clinical trials: Canadian Urologic Oncology Group/Global GU Group

Book ID: 117724154
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 33 KB
Volume: 6
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(01)00146-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy in cooperative clinical tri

Radiotherapy in cooperative clinical trials: Northern California Oncology Group (NCOG) method

✍ Elisabeth A. MacDonald; Macy-Louise Meurk; Gordon Ray; Theodore L. Phillips; Ste 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 834 KB

Pediatric oncology nursing in cooperativ

Pediatric oncology nursing in cooperative group clinical trials comes of age

✍ Kathy Ruccione; Kathy Patterson Kelly 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 759 KB

Radiation therapy oncology group clinica

Radiation therapy oncology group clinical trials with misonidazole

✍ Todd H. Wasserman; Joann Stetz; Theodore L. Phillips 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

Clinical cooperative trials of the natio

Clinical cooperative trials of the national cancer institute of Canada clinical trials group breast cancer site group

✍ Kathleen I. Pritchard 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Creating a Novel Structure for Nursing R

Creating a Novel Structure for Nursing Research in a Cooperative Clinical Trials Group: The Children’s Oncology Group Experience

✍ Kathleen S. Ruccione; Pamela S. Hinds; Joetta DeSwarte Wallace; Katherine Patter 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Primary liver cancer. An eastern coopera

Primary liver cancer. An eastern cooperative oncology group trial

✍ Geoffrey Falkson; John M. MacIntyre; Charles G. Moertel; Lewis A. Johnson; R. C. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 809 KB

One hundred ninety-two patients with unresectable primary liver cancer studied by members of the Eastern Cooperative Oncology Group (ECOG) were evaluable in a prospectively randomized clinical trial. Patient discriminants such as performance status were carefully evaluated to assess their influence